Blog – Page 40 – Melanoma Research Foundation

Blogs Events Featured Melanoma News Press Release

Blogs |

December 3, 2015

Rare Cancer Community Unites to Drive Research for...

Through the Melanoma Research Foundation’s #CUREOM Unite! Campaign, Ocular Melanoma Patients Help Fund and Review Research Grant Washington, DC – T...

5 Minute Read

Blogs |

December 1, 2015

Moses – #GivingTuesday 2015

#GivingTuesday is almost over but it’s not too late to give a gift to the Melanoma Research Foundation (MRF) to help stop melanoma in its path. Christy and Dan share why ...

2 Minute Read

Blogs |

December 1, 2015

Carola – #GivingTuesday 2015

Today is #GivingTuesday! Read why Carola Supports the MRF. Melanoma is one of the fastest growing cancers in the world. Today, however, people across the globe stand...

2 Minute Read

Press Release |

November 30, 2015

Sheila – #GivingTuesday 2015

#GivingTuesday is TOMORROW! Join Sheila in Supporting the MRF. #GivingTuesday is in less than 24 hours! Your tax-deductible gift received on #GivingTuesday will help...

2 Minute Read

Blogs |

November 30, 2015

Graham – #GivingTuesday 2015

#GivingTuesday is TOMORROW, December 1! Join Graham in Supporting the MRF. During the holiday season, we are especially grateful for the children in our lives and th...

2 Minute Read

Blogs |

November 25, 2015

Julie & Amelia – #GivingTuesday 2015

#GivingTuesday is Tuesday, December 1, 2015! Join Julie and Amelia in Supporting the MRF. #GivingTuesday is Tuesday, December 1 and your gift to the Melanoma Researc...

2 Minute Read

Press Release |

November 12, 2015

Guest Post: Dr. Sacks, Ocular Melanoma and Gratitu...

Ocular melanoma survivor Anne Marie Montijo reflects on the passing of Dr. Oliver Sacks and her own goal to live each day with a spirit of gratitude.

3 Minute Read

Blogs |

November 10, 2015

FDA Approves New Targeted Therapy Combination (Vem...

Today, the FDA approved the targeted therapy combination of vemurafenib (Zelboraf®) with cobimetinib (Cotellic) for people who have advanced or metastatic melanoma and who...

4 Minute Read

Blogs |

November 6, 2015

Washington, D.C. Community Combats Melanoma at 7th...

Washington, D.C. – On Saturday, November 7th, the Washington, D.C. melanoma community will come together to honor those who have been impacted by melanoma and raise f...

4 Minute Read

Press Release |

October 30, 2015

#CUREOM Unite! – Thank You!

The results are in and #CUREOM Unite! was a tremendous success! Thank you to everyone who gave so generously to this campaign to further patient-centered ocular melanoma (O...

2 Minute Read

Blogs |

October 27, 2015

FDA Approves First New Adjuvant Treatment for Stag...

Statement from Tim Turnham, Executive Director, Melanoma Research Foundation Washington, D.C.—Today the Food and Drug Administration (FDA) approved ipilimumab ...

3 Minute Read

Press Release |

October 27, 2015

FDA Approves Talimogene Laherparepvec (T-VEC) for ...

Today the FDA approved Amgen’s drug, Imlygic (Talimogene Laherparepvec or T-VEC), for the treatment of unresectable Stage IIIB, IIIC or IV metastatic melanoma, bringing a...

3 Minute Read